Search Orphan Drug Designations and Approvals
-
Generic Name: | miltefosine |
---|---|
Date Designated: | 12/06/2016 |
Orphan Designation: | Treatment of primary amebic encephalitis (PAM) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Profounda, Inc. 5790 Hoffner Avenue Suite 507 Orlando, Florida 32822 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-